Advanced search    

Search: authors:"Donna M. Evon"

2 papers found.
Use AND, OR, NOT, +word, -word, "long phrase", (parentheses) to fine-tune your search.

A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic hepatitis C: Results from a large US multi-center observational study

of the manuscript. Competing interests: Donna M. Evon has received research funding from Gilead. Michael Fried has received research funding from and served as a consultant for AbbVie, BMS, Gilead ... Gastroenterology Associates), William King, Megan Marles (Wilmington Gastroenterology Associates). Author Contributions Conceptualization: Donna M. Evon, Paul W. Stewart, Carol E. Golin, Bryce B. Reeve, David R

Fatigue during treatment for hepatitis C virus: results of self-reported fatigue severity in two Phase IIb studies of simeprevir treatment in patients with hepatitis C virus genotype 1 infection

Background Fatigue is a common symptom of chronic hepatitis C virus (HCV) infection and a frequent side-effect of peginterferon/ribavirin (PR) therapy for HCV. This study evaluated the impact of adding the oral HCV NS3/4A protease inhibitor simeprevir to PR on patient-reported fatigue and health status among patients with chronic HCV genotype 1 infection enrolled in the Phase IIb...